Analysis of Once-Daily Thoracic Radiotherapy Dose According to the Underlying Lung Disease in Patients with Limited-Stage Small Cell Lung Cancer Undergoing Concurrent Chemoradiotherapy

PURPOSE: In the treatment of concurrent chemoradiotherapy (CCRT) in limited-stage small cell lung cancer, the optimal once-daily radiotherapy (RT) dose/fractionation remain unclear although it is the most frequently used. Therefore, this study aimed to compare the treatment outcomes and toxicities o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Byoung Hyuck, Chung, Joo-Hyun, Son, Jaeman, Kim, Suzy, Wu, Hong-Gyun, Kim, Hak Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873322/
https://www.ncbi.nlm.nih.gov/pubmed/35287254
http://dx.doi.org/10.4143/crt.2021.1202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873322/
https://www.ncbi.nlm.nih.gov/pubmed/35287254
http://dx.doi.org/10.4143/crt.2021.1202

Ejemplares similares